A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's

Saved in:
Bibliographic Details
Title: A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's
Authors: Tornling, G, Edenius, C, Pauling, JD, Denton, CP, Olsson, A, Kowalski, J, Murray, A, Anderson, M, Bhat, S, Del, Galdo F
Source: RHEUMATOLOGY. 64(2):704-713
Access URL: http://kipublications.ki.se/Default.aspx?queryparsed=id:154970472
Database: SwePub
Description
ISSN:14620324
DOI:10.1093/rheumatology/keae049